BROOMFIELD, Colo., Sept. 3 /CNW/ -- Embla and Covidien have entered into
a definitive agreement under which Embla will acquire Covidien's Sleep
Diagnostic business. This includes the sleep diagnostic products sold under
the Sandman(TM) brand name. Financial terms of the transaction were not
disclosed. Completion of the sale is subject to customary closing conditions.
The combined entity will form the world's largest company to focus
entirely on sleep diagnostics, with close to 1700 customers in North America
and about 2500 worldwide. Embla offers market leading sleep diagnostic
products, support and service.
Both Sandman and Embla have leading brand names in North America where it
is estimated that over 40 million people suffer from some form of sleep
disorder. Up to seventy percent of patients who have suffered a stroke and
sixty percent of congestive heart failure patients also suffer from sleep
"You can't open a newspaper or magazine today without seeing something
about sleep. We know it impacts every aspect of our lives and this acquisition
puts us at the forefront of the industry," said David Baker, President and CEO
of Embla Systems.
Embla's global headquarters is based in Colorado, and the company has a
significant Research & Development and Technical Support presence in their
Ottawa, Canada office. The Covidien Sandman Sleep Diagnostic business is also
headquartered in Ottawa, Canada.
About Embla Systems
Embla is the leader in the global sleep diagnostic market, creating
medical solutions for sleep professionals and delivering value through
innovative products and service excellence. The privately held company
manufactures, distributes and services its products in over 65 countries.
Embla has 120 employees worldwide with offices in Broomfield, CO; Buffalo, NY;
Ottawa, Canada; Amsterdam; Netherlands; and Munich, Germany.
Please visit www.embla.com and www.sandmansleep.com to learn more about
our business or www.closertoourcustomers.com to learn more about this
For further information:
For further information: David Baker, President CEO, +1-303-962-1780,
email@example.com, or Kristen Pickard, Marketing Manager, +1-303-962-1795,
firstname.lastname@example.org, both of Embla Systems; Investor inquiries, Embla
Systems is a privately held company. Web Site: http://www.embla.com